Dr Reddy’s bags exclusive distribution rights of Takeda’s dengue vaccine QDENGA in India

The Hindu Business Line - Sep 18, 2026

Takeda’s two-dose dengue vaccine has been approved by CDSCO for people aged 4-60 and is expected to enter India’s private market in the first half of 2027.

Read full article
More News
Copyright © 2015 - 2026 The Financial Capital.

All Rights Reserved.

Subscribe Now!

About Us

The Financial Capital is your independent source for finance information and advice. We provide insights and offer advice from financial experts so you can make the best decisions.